Glooko Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 192

Employees

  • Latest Deal Type
  • Series F

  • Latest Deal Amount
  • $100M

  • Investors
  • 15

Glooko General Information

Description

Developer of a remote patient-monitoring platform intended to identify at-risk patients and provide quality-enhancing interventions. The company's platform synchronizes with diabetes devices, fitness wearables, and activity trackers to enable data capture and provide reports and analytics that aim to drive behavior change and outcomes, enabling healthcare providers to support remote monitoring efforts to improve patient care.

Contact Information

Website
www.glooko.com
Formerly Known As
OTA Health
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 579 University Avenue
  • Palo Alto, CA 94301
  • United States
+1 (650)
Primary Industry
Enterprise Systems (Healthcare)
Vertical(s)
TMT, HealthTech
Corporate Office
  • 579 University Avenue
  • Palo Alto, CA 94301
  • United States
+1 (650)

Glooko Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glooko Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series F) 10-Oct-2024 $100M Completed Generating Revenue
11. Later Stage VC 17-Aug-2023 Completed Generating Revenue
10. Secondary Transaction - Private 01-Jul-2022 Completed Generating Revenue
9. Debt - General 30-Sep-2021 Completed Generating Revenue
8. Later Stage VC (Series D) 16-Mar-2021 Completed Generating Revenue
7. Debt - PPP 10-Apr-2020 Completed Generating Revenue
6. Later Stage VC (Series C1) 13-Jul-2019 Completed Generating Revenue
5. Later Stage VC (Series C) 27-Jun-2017 Completed Generating Revenue
4. Later Stage VC (Series B) 20-Oct-2016 $24.5M $40.7M Completed Generating Revenue
3. Early Stage VC (Series A1) 08-Jan-2014 $7M $16.2M Completed Startup
To view Glooko’s complete valuation and funding history, request access »

Glooko Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series E
Series D
Series C1
Series C
Series B
Series A1
Series A 642,700 $0.001000 $0.8 $10 $10 1x $1.79 2.43%
Seed 694,135 $0.001000 $0.16 $2 $2 1x $0.94 1%
To view Glooko’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Glooko Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a remote patient-monitoring platform intended to identify at-risk patients and provide quality-enhancing in
Enterprise Systems (Healthcare)
Palo Alto, CA
192 As of 2021

New York, NY
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Glooko Competitors (15)

One of Glooko’s 15 competitors is DarioHealth, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DarioHealth Formerly VC-backed New York, NY
Wellframe Private Equity-Backed Boston, MA
Ascensia Diabetes Care Formerly PE-Backed Basel, Switzerland
Monarch Medical Technologies Formerly PE-Backed Charlotte, NC
Health2Sync Venture Capital-Backed Taipei, Taiwan
You’re viewing 5 of 15 competitors. Get the full list »

Glooko Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

Glooko Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10373519-B1 System and method for determining and providing activity recommendations Active 26-Sep-2016
US-10321859-B1 Systems and methods for capturing and analyzing hypoglycemic event data Active 25-Feb-2014
US-11497420-B2 Capturing and analyzing hypoglycemic event data to identify treatment options Active 25-Feb-2014
US-20190298236-A1 Capturing and analyzing hypoglycemic event data to identify treatment options Active 25-Feb-2014
US-9292475-B1 Method and system for processing information Active 24-Dec-2013 G06F17/10
To view Glooko’s complete patent history, request access »

Glooko Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Glooko Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Realization Capital Partners PE/Buyout Minority
Health Catalyst Capital Management Growth/Expansion Minority
Novo Nordisk Corporation Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 15 investors. Get the full list »

Glooko Investments & Acquisitions (3)

Glooko’s most recent deal was a Buyout/LBO with Diabnext. The deal was made on 16-Mar-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Diabnext 16-Mar-2022 Buyout/LBO Monitoring Equipment
xbird 01-Dec-2021 Merger/Acquisition Other Healthcare Technology Systems
Diasend 13-Sep-2016 Merger/Acquisition Medical Records Systems
To view Glooko’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Glooko Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Diabnext Paris, France 2016
xbird Berlin, Germany 2015

Glooko FAQs

  • When was Glooko founded?

    Glooko was founded in 2010.

  • Where is Glooko headquartered?

    Glooko is headquartered in Palo Alto, CA.

  • What is the size of Glooko?

    Glooko has 192 total employees.

  • What industry is Glooko in?

    Glooko’s primary industry is Enterprise Systems (Healthcare).

  • Is Glooko a private or public company?

    Glooko is a Private company.

  • What is Glooko’s current revenue?

    The current revenue for Glooko is .

  • How much funding has Glooko raised over time?

    Glooko has raised $524M.

  • Who are Glooko’s investors?

    Realization Capital Partners, Health Catalyst Capital Management, Novo Nordisk, , and are 5 of 15 investors who have invested in Glooko.

  • Who are Glooko’s competitors?

    DarioHealth, Wellframe, Ascensia Diabetes Care, Monarch Medical Technologies, and Health2Sync are some of the 15 competitors of Glooko.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »